- Home
- SSTI vs STRO Comparison
SSTI vs STRO Comparison
Compare SSTI & STRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SSTI | STRO |
|---|---|---|
| Founded | 1996 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 92.1M | 85.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | SSTI | STRO |
|---|---|---|
| Price | $7.30 | $20.45 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | $15.80 | ★ $18.88 |
| AVG Volume (30 Days) | ★ 223.3K | 116.6K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $34,753,000.00 | N/A |
| Revenue This Year | $3.98 | $63.08 |
| Revenue Next Year | $9.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 46.25 | N/A |
| 52 Week Low | $5.78 | $0.52 |
| 52 Week High | $18.65 | $20.59 |
Technical Indicators
Market Signals| Indicator | SSTI | STRO |
|---|---|---|
| Relative Strength Index (RSI) | 48.08 | 73.10 |
| Support Level | $5.81 | $0.76 |
| Resistance Level | $7.73 | N/A |
| Average True Range (ATR) | 0.54 | 1.70 |
| MACD | 0.04 | 0.27 |
| Stochastic Oscillator | 44.49 | 94.68 |
Price Performance
Historical ComparisonAbout SSTI SoundThinking Inc.
SoundThinking Inc is a public safety technology company that combines transformative solutions and strategic advisory services for law enforcement and civic leadership. Its flagship SafetySmart platform includes ShotSpotter, the acoustic gunshot detection system, CrimeTracer, the foremost law enforcement search engine, CaseBuilder, a one-stop investigation management system, and ResourceRouter, software that directs patrol and community anti-violence resources to help maximize their impact.
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.